About
Technology
Therapeutics
Partnering
Careers
Newsroom
Publications
Contact
Twitter
Linkedin
info@bighatbio.com
About
About
Technology
NEW
Technology
NEW
Therapeutics
Therapeutics
Partnering
Partnering
Careers
Careers
Newsroom
Newsroom
Publications
Publications
Twitter
Twitter
Linkedin
Linkedin
Contact Us
The Latest
Newsroom
All
Announcements
Press
Publications
Presentations
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
5/5/2026
Engineering antibodies to know when NOT to attack: first-in-class logic-gated T cell engagers
Blog
1/7/2026
BigHat Biosciences Partners with Lilly to Advance Machine Learning–Enabled Biologics Discovery Through Lilly TuneLab
Press
Recent Posts
2/27/2024
BigHat’s CIO on Software Engineering Daily podcast
Announcements
12/5/2023
AbbVie and BigHat Biosciences Announce Research Collaboration to Leverage Artificial Intelligence and Machine Learning to Discover Next-Generation Therapeutic Antibodies
Press
10/26/2023
BigHat on Genetic Engineering & Biotechnology News
Press
8/2/2023
BigHat’s CSO on Biocom CA’s Lifelines Podcast
Announcements
6/8/2023
BigHat’s CSO presents at Antibody Engineering and Therapeutics Conference Europe 2023
Presentations
6/1/2023
BigHat Appoints John Corbin, PhD as Chief Development Officer
Announcements
12/21/2022
BigHat Year in Review 2022
Announcements
11/29/2022
BigHat Biosciences Announces Research Collaboration with Merck
Announcements
9/29/2022
BigHat Biosciences validates best-in-class security posture with spotless SOC2 audit
Announcements
7/20/2022
BigHat Biosciences Raises $75 Million in Series B Funding to Design Safer, More Effective Antibodies
Announcements
6/23/2022
BigHat’s CSO and VP Engineering speaking at AWS Summit San Francisco
Announcements
5/11/2022
BigHat Biosciences Appoints Rob Chess, Serial Entrepreneur, to its Board of Directors
Announcements
Previous
2 / 5
Next
© BigHat Bio 2026